The research protocol driven follow-up angiogram will be performed at no cost to the patient or their insurance carrier. The rapamycin-coated stent is currently an investigational device and this protocol has been approved by the Institutional Review Board of The Christ Hospital. This study combines two blood-thinning drugs to provide the fastest drug treatment for heart attack victims. These medications combine to break down the blood clots that cause a heart attack, and prevent other blood cells and platelets from sticking together to form new clots. As a result, blood clots dissolve and do not reappear, allowing vital blood and oxygen to be carried to the heart muscle before it is destroyed.
Patients commonly experience rapid relief of their heart attack symptoms.